封面
市場調查報告書
商品編碼
2075969

放射性示踪劑市場:按類型、應用、最終用戶和地區分類

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,放射性示蹤劑市場規模將達40億美元,到2033年將達到65.9億美元。預計從2026年到2033年,該市場將以7.4%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 40億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.40% 2033年市場規模預測: 65.9億美元

全球放射性示蹤劑市場涵蓋多種產品,包括用於腫瘤學、循環系統和神經病學等領域的「診斷用放射性示蹤劑」和「治療放射性示蹤劑」。醫院和專科診所對放射性示蹤劑的日益普及以及對更有效率、更可靠解決方案的需求,是推動市場成長的主要因素。持續的技術進步和終端用戶需求的不斷成長,也進一步促進了該市場的發展。

市場動態:

腫瘤學和循環系統領域放射性示踪劑應用範圍的擴大、終端用戶需求的成長以及對提高效率和性能的持續關注,預計將是推動全球放射性示踪劑市場成長的主要因素。更多種類的選擇也使得更廣泛的使用者群體能夠使用這些解決方案。

例如,各公司正在拓展產品系列,以滿足醫院和專科診所不斷變化的需求。此外,預計在預測期內,加大創新投入和整合新技術將為市場參與者創造新的成長機會。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務績效和策略等參數,介紹了全球放射性示蹤劑市場主要參與者的概況。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球放射性示踪劑市場報告的目標受群眾外包括行業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球放射性示蹤劑市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 慢性病盛行率增加
    • 放射性藥物的半衰期很短。
    • 腫瘤學領域的新應用
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球放射性示蹤劑市場:依類型分類,2021-2033年

  • 診斷用放射性示蹤劑
  • 治療性放射性示蹤劑
  • 其他

第5章 全球放射性示蹤劑市場:依應用領域分類,2021-2033年

  • 腫瘤學
  • 循環系統
  • 神經病學
  • 甲狀腺
  • 整形外科
  • 內分泌學
  • 其他

第6章 全球放射性示蹤劑市場:依最終用戶分類,2021-2033年

  • 醫院
  • 專科診所
  • 診斷中心
  • 學術研究機構
  • 其他
  • 市場規模及預測、年增速分析

第7章 全球放射性示蹤劑市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • PerkinElmer Inc.
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion(Canada)Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6389

Radioactive Tracer Market is estimated to be valued at USD 4.00 Bn in 2026 and is expected to reach USD 6.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4.00 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.40% 2033 Value Projection: USD 6.59 Bn

The global radioactive tracer market covers a broad set of type categories, including Diagnostic Radioactive Tracers, and Therapeutic Radioactive Tracers, used across applications such as Oncology, Cardiology, and Neurology. Demand is supported by adoption among Hospitals, and Specialty Clinics and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Oncology, and Cardiology, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global radioactive tracer market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Specialty Clinics. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global radioactive tracer market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include PerkinElmer Inc., Cardinal Health, Bracco, NTP Radioisotopes, Nordion (Canada) Inc., Curium, IRE, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes, LLC, Lantheus Holdings, Inc., Eckert & Ziegler, Siemens Healthineers, GE Healthcare, Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., and Sumitomo Heavy Industries, Ltd, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market.

Detailed Segmentation:

  • Global Radioactive Tracer Market, By Type (Revenue, USD Bn, 2021 - 2033)
  • Diagnostic Radioactive Tracers
  • Therapeutic Radioactive Tracers
  • Others
  • Global Radioactive Tracer Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Orthopedic
  • Endocrinology
  • Others
  • Global Radioactive Tracer Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles:
  • PerkinElmer Inc.*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market, Radioactive Tracer, By Type
    • Market Radioactive Tracer, By Application
    • Market Radioactive Tracer, By End User
    • Market Radioactive Tracer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of chronic diseases
    • Short half-life of radiopharmaceuticals
    • Emerging applications in oncology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Radioactive Tracer Market, By Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Diagnostic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Therapeutic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Radioactive Tracer Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Thyroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Radioactive Tracer Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Others
    • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Radioactive Tracer Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2022 -2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,( US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bracco
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NTP Radioisotopes
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Nordion (Canada) Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Curium
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IRE
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Telix Pharmaceuticals Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NorthStar Medical Radioisotopes, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lantheus Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Eckert & Ziegler
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Mallinckrodt Nuclear Medicine LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Jubilant DraxImage Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sumitomo Heavy Industries, Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us